Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Levamlodipine besilate (substance) |
Is modification of (attribute) |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levamlodipine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levamlodipine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing levamlodipine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levamlodipine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atenolol 50 milligram and levamlodipine (as levamlodipine besilate) 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atenolol and levamlodipine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atenolol- and levamlodipine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only atenolol and levamlodipine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atenolol 50 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atenolol- and levamlodipine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide and levamlodipine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing hydrochlorothiazide and levamlodipine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide- and levamlodipine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 12.5 mg and levamlodipine (as levamlodipine besilate) 2.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only hydrochlorothiazide and levamlodipine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Levamlodipine (as levamlodipine besilate) 2.5 mg and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing levamlodipine and metoprolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only levamlodipine and metoprolol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing levamlodipine and metoprolol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only levamlodipine and metoprolol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Levamlodipine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |